biotech
biotech Articles
CureVac stock exploded into the market, more than double its original pricing. Since then, it is up more or less triple its original pricing.
Published:
Taiwan Liposome Co. Ltd (NASDAQ: TLC) shares shot higher on Friday after the company announced it was making a regulatory filing for a COVID-19 treatment that has been at the center of some...
Published:
When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of “sell the news,” because this is ultimately a net positive for the company.
Published:
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Eyenovia shares soared on Tuesday after the company announced an exclusive license agreement with Artic Vision.
Published:
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
Published:
Seres Therapeutics shares more than tripled early on Monday after the firm announced positive late-stage results for its C. difficile infection study.
Published:
AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.
Published:
The world may be focused on COVID-19 this year, but the battle against Alzheimer’s disease continues with no effective treatments. Biogen hopes to remedy that unfortunate situation.
Published:
Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.
Published:
Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine study.
Published:
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be...
Published:
Regeneron Pharmaceuticals, one of the front-runners for the development of a COVID-19 treatment, released an update on its antibody drug combination on Monday.
Published:
Alterity Therapeutics stock more than doubled on Tuesday after the company announced new data for its lead drug candidate for the treatment of multiple system atrophy.
Published:
Amarin reported its latest quarterly results on Tuesday morning and gave an update on the most recent developments with its blockbuster drug Vascepa.
Published: